Weave integrates with Neo to enhance veterinary practice management

Published 21/07/2025, 15:08
Weave integrates with Neo to enhance veterinary practice management

LEHI, Utah - Weave (NYSE:WEAV), a customer experience software platform for small and medium-sized healthcare businesses with annual revenue of $213 million and impressive revenue growth of 20%, announced Monday a new integration with Neo, a cloud-based veterinary practice management software. According to InvestingPro data, the company maintains a strong gross profit margin of 72%, demonstrating efficient service delivery.

The integration enables veterinary practices to access several Weave features designed to streamline operations and improve client communication. These features include automated appointment reminders with confirmation writebacks, regular data synchronization between systems, client profile display during incoming calls, automated vaccination reminders, review collection tools, missed-call text messaging, and text message documentation in patient management systems.

According to the press release statement, the integration aims to help veterinary practices manage client relationships more efficiently while reducing administrative work. The software combination allows practices to maintain up-to-date client contact information and appointment details through automated data synchronization between platforms. While the company holds more cash than debt on its balance sheet, InvestingPro analysis reveals additional insights about Weave’s financial health and growth potential in their comprehensive Pro Research Report, available with a subscription.

The integration also incorporates Weave’s payment processing capabilities, offering text-to-pay functionality, online payment options, and payment plans to help practices manage their revenue collection.

Weave’s software is designed to connect various aspects of the patient journey from initial contact through final billing. The company was recently recognized as an Inc. Power Partner and a G2 leader in Patient Relationship Management software, according to the announcement.

The integration is now available for veterinary practices using Neo’s practice management system. With Weave’s earnings report due in 10 days, investors can access detailed financial analysis, Fair Value estimates, and 6 additional ProTips through InvestingPro’s extensive coverage of over 1,400 US stocks.

In other recent news, Weave Communications Inc. reported a strong first-quarter performance for fiscal year 2025, with revenue increasing by 18.3% year-over-year to $55.8 million, slightly above the forecasted $54.74 million. The company’s earnings per share (EPS) met expectations at $0.01. Weave Communications also announced the acquisition of TrueLark for $35 million, a move that is expected to enhance its AI capabilities and expand its market potential. Analysts at Stifel have maintained a Buy rating on Weave, reiterating a $16 price target, while Piper Sandler increased the stock’s price target to $15, maintaining an Overweight rating. Loop Capital adjusted the price target to $16 from $18, maintaining a Buy rating, and Goldman Sachs raised the target to $11, keeping a Neutral stance. Despite these varied analyst ratings, the company’s strategic acquisitions and strong performance in the specialty medical segment have been highlighted as key drivers of growth. Weave has also raised its full-year revenue guidance to between $236.8 million and $239.8 million, reflecting confidence in its growth trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.